Previous 10 | Next 10 |
2024-02-18 11:27:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Growth Fund (the Fund) gained 7.70% (Institutional Shares) for the quarter and 1...
2024-02-18 07:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron WealthBuilder Fund appreciated 11.42% (inst.) in Q4 2023, and for 2023, the Fund...
2024-02-17 10:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund increased 9.74% (inst. shares) in Q4 2023 underperforming th...
2024-02-17 05:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund was up 12.64% (Institutional Shares) in Q4 2023 and gained 27.19%...
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect Canada NewsWire Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits WESTBROOK, Maine , ...
2024-02-07 07:58:28 ET Summary IDEXX Laboratories reported strong financial performance in 4Q23, with an 8% increase in organic revenues. The company experienced growth in its Companion Animal Group segment, particularly in diagnostic recurring revenue. IDEXX's outlook include...
A look at the top 10 most actives in the United States Phunware Inc. (PHUN) rose 19.9% to $0.41 on volume of 260,182,609 shares Palantir Technologies Inc. Class A (PLTR) fell 1.8% to $16.72 on volume of 167,698,349 shares PROSHARES TRUST (SQQQ) rose 0.5% to $11.78 on volume of 155,646,888...
2024-02-05 12:02:03 ET IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Conference Call February 05, 2024, 8:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conf...
2024-02-05 06:34:13 ET More on IDEXX Laboratories IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified Piper Sandler downgrades Idexx to neutral, cites macro headwinds Seeking Alpha’s Quant Rating on IDEXX Laboratories Historical earnings data...
Achieves fourth quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 11% reported and 10% organic Solid growth supported by continued benefits from IDEXX execution drivers, including 11% year-over-year expansion of IDEXX's global prem...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 2.72% on an annualized basis producing an average annual ret...
2024-05-28 08:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...